ETF DAILY NEWS

Analysts Set Replimune Group, Inc. (NASDAQ:REPL) PT at $19.43

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, Marketbeat reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price […]

Mar 20, 2025 - 06:17
 0
Analysts Set Replimune Group, Inc. (NASDAQ:REPL) PT at $19.43
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, Marketbeat reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price […]
Read More

Tags:

Previous Article

Innovation Beverage Group Limited’s Lock-Up Period Will End on March 25th (NASD...

Next Article

Brookfield Co. (NYSE:BN) Receives $64.00 Average Price Target from Brokerages

Related Posts

Piper Sandler Has Lowered Expectations for Freshpet (NASDAQ:FRPT) Stock Price

Piper Sandler Has Lowered Expectations for Freshpet (NA...

Mar 26, 2025  0

Capri Holdings Limited (NYSE:CPRI) Receives $25.92 Consensus Target Price from Analysts

Capri Holdings Limited (NYSE:CPRI) Receives $25.92 Cons...

Mar 12, 2025  0

Barclays Has Lowered Expectations for ConocoPhillips (NYSE:COP) Stock Price

Barclays Has Lowered Expectations for ConocoPhillips (N...

Feb 11, 2025  0